MCG In Long QT Syndrome

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT07270211
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Magnetocardiography — DIAGNOSTIC_TEST
    MCG is a non-invasive, radiation-free imaging technique that detects the magnetic field generated by the electrical activity of the heart.

Study Details

The primary objective of this observational study is to evaluate whether magnetocardiography (MCG) findings more accurately predict clinical outcomes in patients with acquired Long QT syndrome compared to ECG. The secondary objective is to assess differences in QT interval length between MCG and ECG. The primary safety objective is to characterize the safety profile of the CardiAQ MCG device.

Key Dates

Start date
Apr 30, 2026
Status verified
Mar 2026
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
100 participants (estimated)

Arms

  • Arm: Subjects diagnosed with atrial fibrillation

Primary Outcome Measure

Number of successful dofetilide loading using Magnetocardiography [ Time Frame: Baseline ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo Clinic in RochesterRochesterMinnesota55905
Structural Heart Research Team
(507) 255-6133
Mohamad Alkhouli, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Rochester, MN

By condition
Atrial fibrillation
By specialty
CardiologyHeart disease
By research site
Mayo Clinic in Rochester· Rochester, MN

Related Studies